Navigation Links
From GM farm animals to embryonic stem cell research
Date:10/23/2007

Genomics and Society: Todays Answers, Tomorrows Questions taking place in London on Thursday 25 and Friday 26 October 2007 - brings together policymakers, researchers and natural scientists with what is becoming the worlds largest concentration of social scientific research in the field of genomics - the Economic and Social Research Council (ESRC) Genomics Network (EGN).

DNA, genes and chromosomes are often described as the 'genetic information' that makes us what we are at birth. By considering together all this material from an organism, scientists find what they call its genome.

Genomics is the science of these genomes - their sequencing, mapping, analysis, and manipulation all central to developments from GM crops and Dolly the sheep to DNA fingerprinting or treating diabetes and liver disease in humans.

This weeks landmark gathering provides a showcase for important research findings from the first five years of work by the ESRC Genomics Network ranging across five UK universities and involving more than 100 researchers as well as examining big new questions emerging as it moves on to a second exciting phase.

Embryonic stem cell research, genetic databases and biobanks, and the potential for huge advances in medicine, physical health and psychiatry, feature among topics covered in lectures, debates, seminars and exhibitions. Jon Marks, distinguished author and Professor of Sociology and Anthropology at the University of North Carolina, Charlotte, will deliver a keynote speech, whilst a debate, hosted with the Institute of Ideas, will ensue on the battle over ethics and regulation.

The event is organised by the Networks Genomics Policy and Research Forum, which connects social science research on genomics with public policy debates and decision-making.

Its director, Professor Steve Yearley, said: In the past week we have seen prominent genomics scientists, including Craig Venter and James Watson, bursting into the headlines. Genomics and Society: Todays Answers, Tomorrows Questions gives us a chance to examine the latest findings on how genomics - which embraces a whole range of biological processes from inheritance to development and beyond - is impacting on peoples lives.

The work of the ESRC Genomics Network spans the whole field - covering areas as diverse as plant genetics and issues around GM foods, embryonic stem cell research, health applications through biomedicine and gene therapy, and even creating new forms of life.

This landmark event marking the Networks transition to a new five-year phase of funding, gives the opportunity for a cross-fertilisation of ideas and healthy debate on the past, present and future roles of genomics in society.


Event: Todays Answers, Tomorrows Questions

Venue: One Great George Street, London SW1P 3AA.

Time: From 9.15am on Thursday, October 25 2007

EVENT OUTLINE:

Thursday 25th October

Welcome by Professor Steve Yearley; keynote speech by Jon Marks, University of North Carolina, Charlotte; and presentations from directors of the ESRC Genomics Network research centres.

In depth analyses including:

  • Do DNA databases offer the best route to a healthy population and a secure society";

  • Is genomics the latest technological fix for the developing world";

  • What is driving stem cell research"; and

  • Will genomics revolutionise psychiatry and understanding of the brain";

Friday 26th October

Introduction by Professor Ian Diamond, chief executive of the ESRC and policy sessions including: Public consultation; How to use genetic information to advance public health; and Dolly for Dinner': emerging animal breeding technologies.

Ethics and Regulation: A debate, hosted with the Institute of Ideas, focuses on the draft Human Tissue and Embryos Bill, and concerns and difficult questions raised.


'/>"/>

Contact: Danielle Moore
danielle.moore@esrc.ac.uk
01-793-413-122
Economic & Social Research Council
Source:Eurekalert

Related biology news :

1. Plants, animals share molecular growth mechanisms
2. Elephants imitate truck noises, other animals
3. Gene Therapy For Parkinsons Disease Moves Forward In Animals
4. Carnegie Mellon scientists develop tool that uses MRI to visualize gene expression in living animals
5. Gene therapy for Parkinsons disease moves forward in animals
6. Use of PET can reduce, may eliminate more strenuous drug development trials with animals
7. Undesirable expatriates: Preventing the spread of invasive animals
8. Two new retroviruses—transmitted from animals—identified
9. Stem cell therapy successfully treats heart attack in animals
10. More animals join the learning circle
11. Experimental vaccine protects lab animals against several strains of H5N1
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)... Florida , March 31, 2016 ... ) ("LegacyXChange" or the "Company") LegacyXChange ... potential users of its soon to be launched online ... ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential ... use of DNA technology to an industry that is ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica ... in people with peritoneal or pleural mesothelioma. Their findings are the subject of a ... , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is pleased to announce the launch of their brand, UP4™ Probiotics, into Target ... over 35 years, is proud to add Target to its list of well-respected ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
Breaking Biology Technology: